Yong Sang Hong Selected Research

Yong Sang Hong Research Topics

Disease

70	Neoplasms (Cancer) 01/2024 - 08/2007
68	Colorectal Neoplasms (Colorectal Cancer) 03/2024 - 02/2009
31	Rectal Neoplasms (Rectal Cancer) 06/2022 - 08/2008
16	Colonic Neoplasms (Colon Cancer) 11/2022 - 02/2009
16	Neoplasm Metastasis (Metastasis) 07/2022 - 02/2009
8	Adenocarcinoma 01/2018 - 01/2011
5	Stomach Neoplasms (Stomach Cancer) 01/2024 - 11/2013
5	Neutropenia 11/2023 - 03/2011
5	Pancreatic Neoplasms (Pancreatic Cancer) 12/2020 - 01/2012
4	Nausea 11/2023 - 10/2010
4	Disease Progression 01/2023 - 11/2012
4	Microsatellite Instability 01/2022 - 09/2011
3	Vomiting 11/2023 - 10/2010
3	Diarrhea 04/2014 - 08/2007
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 12/2023 - 01/2017
2	Necrosis 06/2022 - 04/2014
2	Melanoma (Melanoma, Malignant) 01/2021 - 12/2013
2	Hypothyroidism 01/2020 - 12/2019
2	Lymphatic Metastasis 01/2018 - 05/2011
2	Carcinogenesis 10/2016 - 06/2014
2	Lung Neoplasms (Lung Cancer) 04/2015 - 01/2012
2	Fatigue 10/2014 - 07/2010
2	Hand-Foot Syndrome 04/2014 - 08/2007
2	Proteinuria 02/2014 - 02/2013
2	Anorexia 11/2013 - 08/2007
2	Exanthema (Rash) 01/2013 - 10/2011
2	Pathologic Complete Response 01/2013 - 02/2009
1	Edema (Dropsy) 06/2022
1	Fibrosis (Cirrhosis) 06/2022
1	Desmoplastic Small Round Cell Tumor 01/2021

Drug/Important Bio-Agent (IBA)

28	Irinotecan (Camptosar)FDA LinkGeneric 12/2023 - 06/2009
25	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2022 - 06/2009
21	Cetuximab (Erbitux)FDA Link 01/2022 - 06/2009
19	Capecitabine (Xeloda)FDA Link 11/2021 - 08/2007
16	Fluorouracil (Carac)FDA LinkGeneric 12/2023 - 06/2008
10	Bevacizumab (Avastin)FDA Link 03/2024 - 07/2009
10	Leucovorin (Folinic Acid)FDA Link 12/2023 - 10/2011
8	Biomarkers (Surrogate Marker)IBA 01/2023 - 12/2009
7	ErbB Receptors (EGF Receptor)IBA 01/2016 - 06/2009
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2009
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023 - 07/2009
4	Monoclonal AntibodiesIBA 01/2023 - 10/2011
4	Histone Deacetylase InhibitorsIBA 04/2016 - 12/2010
3	Carcinoembryonic AntigenIBA 01/2023 - 07/2009
3	Calcibiotic Root Canal SealerIBA 11/2022 - 01/2015
3	Phosphotransferases (Kinase)IBA 01/2021 - 07/2012
3	regorafenibIBA 01/2020 - 07/2019
3	Gemcitabine FDA Link 04/2016 - 01/2012
3	sepantroniumIBA 04/2015 - 01/2012
3	SurvivinIBA 04/2015 - 01/2012
3	Simvastatin (Zocor)FDA LinkGeneric 02/2015 - 09/2009
3	Paclitaxel (Taxol)FDA LinkGeneric 02/2015 - 10/2007
2	Tyrosine Kinase InhibitorsIBA 01/2024 - 12/2019
2	MucinsIBA 06/2022 - 01/2013
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2022
2	binimetinibIBA 01/2021 - 10/2019
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 10/2016
2	encorafenibIBA 01/2021 - 10/2019
2	Inhibitor of Apoptosis ProteinsIBA 12/2020 - 09/2015
2	Lapatinib (GW572016)FDA Link 12/2018 - 01/2014
2	Trastuzumab (Herceptin)FDA Link 12/2018 - 12/2014
2	Sunitinib (Sutent)FDA Link 01/2017 - 04/2014
2	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 11/2015 - 06/2014
2	Caspase 3 (Caspase-3)IBA 11/2015 - 05/2014
2	XELOXIBA 04/2012 - 01/2012
2	Cisplatin (Platino)FDA LinkGeneric 06/2008 - 08/2007
1	olaparibIBA 03/2024
1	Angiogenesis InhibitorsIBA 01/2024
1	apatinibIBA 01/2024
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2024
1	LutetiumIBA 12/2023
1	Peptide Receptors (Peptide Receptor)IBA 12/2023
1	Radioisotopes (Radionuclides)IBA 12/2023
1	Somatostatin Receptors (Somatostatin Receptor)IBA 12/2023
1	GC1118IBA 12/2023
1	Tumor Biomarkers (Tumor Markers)IBA 01/2023
1	Immune Checkpoint InhibitorsIBA 10/2022
1	B7-H1 AntigenIBA 10/2022
1	N-acetyltalosaminuronic acid (NAT)IBA 06/2022
1	Keratins (Keratin)IBA 05/2022
1	Neurofibromin 1 (Neurofibromin)IBA 01/2022
1	durvalumabIBA 01/2022
1	N- (4- (3- (1H- 1,2,4- triazol- 1- yl)- 4- (3,4,5- trimethoxybenzoyl)phenyl)thiazol- 2- yl)- 2- amino- 3- methylbutanamideIBA 10/2021
1	CaspasesIBA 12/2020
1	Proteasome Endopeptidase Complex (Proteasome)IBA 12/2020

Therapy/Procedure

54	Drug Therapy (Chemotherapy) 01/2023 - 08/2007
28	Therapeutics 03/2024 - 06/2009
23	Chemoradiotherapy 01/2022 - 08/2008
10	Adjuvant Chemotherapy 11/2023 - 07/2010
7	Radiotherapy 07/2022 - 08/2008
4	Combination Drug Therapy (Combination Chemotherapy) 04/2018 - 08/2007
3	Neoadjuvant Therapy 11/2019 - 07/2010
2	Drug Tapering 11/2023 - 01/2021
2	Precision Medicine 07/2023 - 01/2022
2	Radiofrequency Ablation 07/2022 - 07/2013
2	Salvage Therapy 11/2017 - 11/2010
2	Aftercare (After-Treatment) 11/2010 - 07/2009
2	Proctectomy 09/2010 - 07/2010
1	Robotic Surgical Procedures 06/2022
1	Palliative Care (Palliative Therapy) 01/2022